Evaluation of tamoxifen and anastrozole in the prevention of gynecomastia and breast pain induced by bicalutamide monotherapy of prostate cancer

Journal of Clinical Oncology

Volumn 23, Issue 4, 2005, Pages 808-815

  Boccardo, Francesco ^a   Rubagotti, A ^a   Battaglia, M ^a   Di Tonno, P ^a   Selvaggi, P P ^a   Conti, G ^a   Comeri, G ^a   Bertaccini, A ^a   Martorana, G ^a   Galassi, P ^a   Zattoni, F ^a   Macchiarella, A ^a   Siragusa, A ^a   Muscas, G ^a   Durand, F ^a   Potenzoni, D ^a   Manganelli, A ^a   Ferraris, V ^a   Montefiore, F ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; BICALUTAMIDE; HORMONE; PROSTATE SPECIFIC ANTIGEN; TAMOXIFEN; ANILIDE; NITRILE; TESTOSTERONE; TRIAZOLE DERIVATIVE;

ADJUVANT THERAPY; AGED; ARTICLE; BONE MARROW TOXICITY; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; FEVER; GYNECOMASTIA; HORMONE BLOOD LEVEL; HOT FLUSH; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; MASTALGIA; MONOTHERAPY; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PROPHYLAXIS; PROSTATE CANCER; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RASH; RESPIRATORY TRACT DISEASE; SEXUAL FUNCTION; UNSPECIFIED SIDE EFFECT; BLOOD; BREAST DISEASE; MIDDLE AGED; PAIN; PROSTATE TUMOR; PSYCHOLOGICAL ASPECT;

AGED; AGED, 80 AND OVER; ANILIDES; BREAST DISEASES; DOUBLE-BLIND METHOD; GYNECOMASTIA; HUMANS; MALE; MIDDLE AGED; NITRILES; PAIN; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; QUALITY OF LIFE; TAMOXIFEN; TESTOSTERONE; TRIAZOLES;

EID: 20044376091     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.12.013     Document Type: Article

References (18)

1. Iversen P, Tyrrell CJ, Kaisary AV, et al: Casodex (bicalutamide) 150-mg monotherapy compared with castration in patients with previously untreated nonmetastatic prostate cancer: Results from two multicenter randomized trials at a median follow-up of 4 years. Urology 51:389-396, 1998
2. Iversen P, Tyrrell CJ, Kaisary AV, et al: Bicalutamide monotherapy compared with castration in patients with nonmetastatic locally advanced prostate cancer: 6.3 years of followup. J Urol 164:1579-1582, 2000
3. Tyrrell CJ, Kaisary AV, Iversen P, et al: A randomised comparison of 'Casodex' (bicalutamide) 150 mg monotherapy versus castration in the treatment of metastatic and locally advanced prostate cancer. Eur Urol 33:447-456, 1998
4. Boccardo F, Rubagotti A, Barichello M, et al: Bicalutamide monotherapy versus flutamide plus goserelin in prostate cancer patients: Results of an Italian Prostate Cancer Project study. J Clin Oncol 17:2027-2038, 1999
5. Chatelain C, Fourcade RO, Delchambre J: Bicalutamide (Casodex) versus combined androgen blockade (CAB): Open French multicentre study in patients with metastatic prostate cancer. Br J Urol 80:283, 1997 (abstr 1111)
6. See WA, McLeod D, Iversen P, et al: The bicalutamide Early Prostate Cancer Program: Demography. Urol Oncol 6:43-47, 2001
7. See WA, Wirth M, McLeod DG, et al: Bicalutamide as immediate therapy, either alone or as adjuvant to standard care of patients with localized or locally advanced prostate cancer: First analysis of the Early Prostate Cancer Program. J Urol 168:429-435, 2002
8. Tyrrell CJ: Tolerability and quality of life aspects with the anti-androgen Casodex (ICI 176,334) as monotherapy for prostate cancer: International Casodex Investigators. Eur Urol 26: 15-19, 1994(suppl 1)
9. McLeod DG, Iversen P: Gynecomastia in patients with prostate cancer: A review of treatment options. Urology 56:713-720, 2000
10. Decensi A, Torrisi R, Fontana V, et al: Long-term endocrine effects of administration of either a non-steroidal antiandrogen or a luteinizing hormone-releasing hormone agonist in men with prostate cancer. Acta Endocrinol (Copenh) 129:315-321, 1993
11. Anelli TF, Anelli A, Tran KN, et al: Tamoxifen administration is associated with a high rate of treatment-limiting symptoms in male breast cancer patients. Cancer 74:74-77, 1994
12. Boccardo F, Pace M, Rubagotti A, et al: Goserelin acetate with or without flutamide in the treatment of patients with locally advanced or metastatic prostate cancer: The Italian Prostatic Cancer Project (PONCAP) Study Group. Eur J Cancer 29A: 1088-1093, 1993
13. Saltzstein D, Cantwell A, Sieber P, et al: Prophylactic tamoxifen significantly reduces the incidence of bicalutamide-induced gynecomastia and breast pain. Br J Urol 90:120-121, 2002 (abstr PD-4.07)
14. Armitage P, Berry G: Statistical Methods in Medical Research (ed 3). Oxford, United Kingdom, Blackwell, 1994
15. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
16. Peto R, Pike MC, Armitage P, et al: Design and analysis of randomized clinical trials requiring prolonged observation of each patient: II. Analysis and examples. Br J Cancer 35:1-39, 1977
17. Healy MJR: Some problems of repeated measurements, in Bithell JF, Coppi R (eds): Perspectives in Medical Statistics. London, United Kingdom, Academic Press, 1981, pp 155-171
18. Melis GB, Paoletti AM, Petacchi FD, et al: Physiological development, benign diseases and cancer of human breast: Importance of prolactin secretion, in Melis GB (ed): Postmenopausal Hormonal Therapy: Benefits and Risk. New York, NY, Raven Press, 1987, pp 55-65